摘要
目的:研究普瑞巴林治疗神经病理性疼痛的疗效和安全性。方法:抽取我院60例疼痛患者随机分成对照组与观察组,分别应用卡马西平与普瑞巴林治疗,经过4周治疗后,根据VAS疼痛评分和HAMD抑制量表、HAMA焦虑量表评定两组疗效和安全性。结果:观察组评分明显优于对照组,观察组不良反应低于对照组,两组有差异(P<0.05)。结论:普瑞巴林治疗神经病理性疼痛疗效较好,而且安全性较高。
Objective:To evaluate the efficacy and safety of pregabalin on neuropathic pain.Methods:60 patients with pain were randomly divided into the control group and observation group,were treated with carbamazepine and pregabalin respectively.After 4 weeks,the efficacy and safety in two groups were evaluated according to VAS score,HAMD score and HAMA score.Results:The scores in the observation group were better than those in the control group.The adverse reaction in the observation group was fewer than that in the control group.Conclusion:Pregabalin on neuropathic pain is effective,with high safety.
出处
《中医临床研究》
2018年第4期121-122,共2页
Clinical Journal Of Chinese Medicine
